Fund Holdings — CAXTON CORP

Total Portfolio Value:
$2.78M
Total Bought:
$1.03M
Total Sold:
$34.1K
Net Transaction:
+$992.4K
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Space Exploration Techn CorpCL A2,6063,699+1,093$445.3K$558.0K20.04%+$112.6K
New Fortress Energy IncPFD SER A MAND01,214+1,214$0$485.6K17.44%+$485.6K
Berkshire Hathaway Inc DelCL B754839+85$377.1K$417.7K15.00%+$40.5K
Tesla, Inc.(TSLA)0829+829$0$294.3K10.57%+$294.3K
Vanguard Index FdsS P 500 ETF SHS339378+39$233.1K$264.7K9.51%+$31.6K
Alphabet Inc.CL A(GOOG)691769+78$246.9K$264.6K9.50%+$17.7K
Blackstone Inc.(BX)1,5971,780+183$188.2K$199.5K7.17%+$11.3K
Kyverna Therapeutics Inc12,34712,3470$110.0K$84.0K3.02%-$26.1K
Lexeo Therapeutics Inc16,96216,9620$79.0K$57.3K2.06%-$21.6K
Inhibikase Therapeutics Inc28,45327,775-678$57.8K$57.1K2.05%-$681
X4 Pharmaceuticals Inc15,55713,534-2,023$72.7K$39.2K1.41%-$33.4K
Sab Biotherapeutics Inc010,372+10,372$0$32.9K1.18%+$32.9K
Alx Oncology Hldgs Inc20,94620,9460$43.4K$29.1K1.05%-$14.2K
Page 1 of 1
CAXTON CORP — 13F Holdings — Q3 2026 | TickerTrail